April 10, 2012 The Human Cost of FDA Decisions: For a Midwestern Family, A Breakdown in Drug Safety Hits Home Michael Halpern Former Contributor
April 3, 2012 New Allegations of Political and Corporate Pressure on FDA Michael Halpern Former Contributor
March 27, 2012 Three Myths about How the FDA Drug Approval Process Works Michael Halpern Former Contributor
March 23, 2012 Five Reasons Congress Should Support Strong Conflict-of-Interest Standards at FDA Francesca Grifo Former contributor
March 21, 2012 Where the FDA Turns When It Needs Scientific Advice Francesca Grifo Former contributor
March 19, 2012 Vioxx shows what happens when the drug safety system breaks down Francesca Grifo Former contributor
March 13, 2012 For Drugs and Medical Devices, It’s Still a Jungle Out There Michael Halpern Former Contributor
March 7, 2012 Survey: Despite Progress, FDA Scientists Feel Political and Industry Pressure Francesca Grifo Former contributor
January 18, 2012 On Plan B, Did Secretary Sebelius Go Back on a Promise? Michael Halpern Former Contributor
January 6, 2012 Science Advocates Tell PCAST to Engage on Scientific Integrity Francesca Grifo Former contributor
November 14, 2011 Webcast Tomorrow: The FDA, Prescription Drugs, Medical Devices, and Science Michael Halpern Former Contributor
October 31, 2011 Engaging Public Health Scientists at the APHA Meeting Michael Halpern Former Contributor
